Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique

Journal of Clinical Microbiology

Volumn 37, Issue 6, 1999, Pages 1881-1884

  Hacek, Donna M ^a   Dressel, Dana C ^a   Peterson, Lance R ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; POLYMYXIN B; RIFAMPICIN; STREPTOMYCIN; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIUM CULTURE; CLINICAL LABORATORY; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; SERUM BACTERICIDAL ACTIVITY;

BACTERIA (MICROORGANISMS);

EID: 0032958774     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.6.1881-1884.1999     Document Type: Article

References (26)

1. Anhalt, J. P., L. D. Sabath, and A. L. Barry. 1980. Special tests: bactericidal activity, activity of antimicrobics in combination, and detection of betalactamase production, p. 478. In E. H. Lennette, A. Ballows, and W. J. Hausler, Jr. (ed.), Manual of Clinical Microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
2. Armstrong, D., H. Neu, L. R. Peterson, and A. Tomasz. 1995. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb. Drug Resist. 1:1-4.
3. Bamberger, D. M., L. R. Peterson, D. N. Gerding, J. A. Moody, and C. E. Fasching. 1986. Ciprofloxacin, azlocillin, ceftizoxime, and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. J. Antimicrob. Chemother. 18:51-63.
4. Chen, R. F. 1967. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242:173-181.
5. DeGirolani, P. C., and G. Eliopoulos. 1987. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. Clin. Lab. Med. 7:499-513.
6. Fasching, C. E., L. R. Peterson, J. A. Moody, L. M. Sinn, and D. N. Gerding. 1990. Treatment evaluation of experimental staphylococcal infections comparing β-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J. Lab. Clin. Med. 116:697-706.
7. Gerding, D. N., L. R. Peterson, J. A. Moody, and C. E. Fasching. 1985. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits. J. Antimicrob. Chemother. 15(Suppl. A):207-219.
8. Gresser-Burns, M. E., C. J. Shanholtzer, L. R. Peterson, and D. N. Gerding. 1987. Occurrence and reproducibility of the "skip" phenomenon in bactericidal testing of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 6:335-342.
9. Isenberg, H. D. 1988. Antimicrobial susceptibility testing: a critical evaluation. J. Antimicrob. Chemother. 22(Suppl A):73-86.
10. Ishida, K., P. A. Guze, G. M. Kalmanson, K. Albrandt, and L. B. Guze. 1982. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob. Agents Chemother. 21:688-690.
11. James, P. A. 1990. Comparison of four methods for the determination of MIC and MBC of penicillin for viridans streptococci and the implications for penicillin tolerance. J. Antimicrob. Chemother. 25:209-216.
12. MacGowan, A., C. McMullin, P. James, K. Bowker, D. Reeves, and L. White. 1997. External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire. J. Antimicrob. Chemother. 39: 277-284.
13. MacLowry, J. D. 1989. Perspective. The serum dilution test. J. Infect. Dis. 160:624-626.
14. Moody, J. A., C. E. Fasching, L. R. Peterson, and D. N. Gerding. 1987. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 6:59-67.
15. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. National Committee for Clinical Laboratory Standards. Methodology for the serum bactericidal test. Approved Guideline. Document M21-A, in press. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved Guideline. Document M26-A, in press. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Peterson, L. R., and D. N. Gerding. 1980. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev. Infect. Dis. 2:340-348.
19. Peterson, L. R., D. N. Gerding, J. A. Moody, and C. E. Fasching. 1984. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob. Agents Chemother. 25:545-552.
20. Peterson, L. R., D. N. Gerding, H. H. Zinneman, and B. M. Moore. 1977. Evaluation of three newer methods for investigating protein interactions of penicillin G. Antimicrob. Agents Chemother. 11:993-998.
21. Peterson, L. R., J. A. Moody, C. E. Fasching, and D. N. Gerding. 1987. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model. Diagn. Microbiol. Infect. Dis. 7:127-136.
22. Peterson, L. R., E. A. Schierl, and W. H. Hall. 1975. Effect of protein concentration and binding on antibiotic assays. Antimicrob. Agents Chemother. 7:540-542.
23. Peterson, L. R., and C. J. Shanholtzer. 1992. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin. Microbiol. Rev. 5:420-432.
24. Shanholtzer, C. J., L. R. Peterson, M. L. Mohn, J. A. Moody, and D. N. Gerding. 1984. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob. Agents Chemother. 26: 214-219.
25. Suh, B., W. A. Craig, A. C. England, and R. L. Elliott. 1981. Effect of free fatty acids on protein binding of antimicrobial agents. J. Infect. Dis. 143: 609-616.
26. Taylor, P. C., F. D. Schoenknecht, J. C. Sherris, and E. C. Linner. 1983 Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob. Agents Chemother. 23:142-150.